Development of Population Level Serotyping Technology and Antibody Profiling for Infectious Pathogens with focus on Influenza and SARS-CoV-2

Information

• Research Project
• 10193123

• ApplicationId

  10193123

• Core Project Number

  R44CA203629

• Full Project Number

  3R44CA203629-03S1

• Serial Number

  203629

• FOA Number

  PA-18-935

• Sub Project Id

• Project Start Date

  9/5/2016 - 9 years ago

• Project End Date

  8/31/2021 - 4 years ago

• Program Officer Name

  RAHBAR, AMIR M

• Budget Start Date

  9/8/2020 - 5 years ago

• Budget End Date

  8/31/2021 - 4 years ago

• Fiscal Year

  2020

• Support Year

  03

• Suffix

  S1

• Award Notice Date

  9/8/2020 - 5 years ago

Organizations

• ENCODIA, INC.

ABSTRACT The goal of this proposal is to repurpose technology developed for Next-Gen Proteomics to develop a highly-scalable digital serotyping technology for infectious disease analysis, with particular application to influenza and Covid-19. The approach is broadly applicable and should greatly improve upon cost, sensitivity, usability, and throughput of population-level serotyping and greatly improve infectious disease monitoring and surveillance.

IC Name

• Activity

  R44

• Administering IC

  CA

• Application Type

  3

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  728518

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  396

• Ed Inst. Type

• Funding ICs

  NCI:728518\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

• Study Section Name

• Organization Name

  ENCODIA, INC.

• Organization Department

• Organization DUNS

  079752755

• Organization City

  SAN DIEGO

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  92121

• Organization District

  UNITED STATES